66 results
6-K
EX-99.2
QIPT
Quipt Home Medical Corp - Ordinary Shares
15 May 24
Current report (foreign)
5:22pm
to several measures which are believed to be meaningful in the assessment of the Company’s performance. These metrics are non-standard measures under … , execution, assessment, and documentation of its internal control over financial reporting and disclosure controls to remediate the material weakness
F-10/A
QIPT
Quipt Home Medical Corp - Ordinary Shares
9 May 24
Registration of securities (Canada) (amended)
4:06pm
, the Company utilizes certain non-IFRS measures which are believed to be meaningful in the assessment of the Company’s performance. These metrics … or assessment by the Company nor are there any pre-emptive, conversion, exchange, redemption or retraction rights attaching to the Common Shares.
All
40-F/A
2023 FY
QIPT
Quipt Home Medical Corp - Ordinary Shares
2 Apr 24
Annual report (Canada) (amended)
6:03am
Codification after April 5, 2012.
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment
40-F/A
2023 FY
EX-99.3
QIPT
Quipt Home Medical Corp - Ordinary Shares
2 Apr 24
Annual report (Canada) (amended)
6:03am
to be meaningful in the assessment of the Company’s performance. These metrics are non-standard measures under IFRS and may not be identical to similar measures … by the Committee of Sponsoring Organizations of the Treadway Commission. Management's assessment included an evaluation of the design of our internal
F-10/A
QIPT
Quipt Home Medical Corp - Ordinary Shares
26 Mar 24
Registration of securities (Canada) (amended)
9:19am
in the assessment of the Company’s performance. These metrics are non-standard measures under IFRS and may not be identical to similar measures … liabilities. The issued Common Shares are not subject to call or assessment by the Company nor are there any pre-emptive, conversion, exchange
6-K
EX-99.2
khzzceu 3s2m
14 Feb 24
Current report (foreign)
5:12pm
F-10
dtr346 naqobl
22 Dec 23
Registration of securities (Canada)
4:42pm
40-F
EX-99.1
8u5xtuvx8a5x9qisu
21 Dec 23
Annual report (Canada)
5:57pm
40-F
cti6vji0itj9 322ik
21 Dec 23
Annual report (Canada)
5:57pm
40-F
EX-99.3
hvuad3yvg0ie8bc
21 Dec 23
Annual report (Canada)
5:57pm
40-F
EX-99.2
4frxgf tj
21 Dec 23
Annual report (Canada)
5:57pm
6-K
EX-99.2
qqe2nr n3xydgcjugr
14 Aug 23
Current report (foreign)
4:19pm
6-K
EX-99.2
pzcmrnkr
16 May 23
Current report (foreign)
7:43am
6-K
EX-99.1
qq020wm
16 May 23
Equity Distribution Agreement
6:03am
SUPPL
1imr 0jxf
15 May 23
Supplemental materials (foreign)
9:59pm
40-F
EX-99.1
xwfhbjn4i5iuyybjdtx
23 Dec 22
Annual report (Canada)
9:18am
40-F
5amv5 wlr3u
23 Dec 22
Annual report (Canada)
9:18am
40-F
EX-99.3
nqx8nq2df 8ros
23 Dec 22
Annual report (Canada)
9:18am
40-F
EX-99.2
xb4e8p6 wsko96sbtgyf
23 Dec 22
Annual report (Canada)
9:18am
6-K
EX-99.1
dse2fkib
21 Dec 22
Posts Strong Adjusted Ebitda Margin of 20.9% for Fiscal Year 2022
9:43pm